Telos Biotech parent, Cambrian Bio, to develop robust cell therapies for treating age-related diseases
Longevity Technology - 27-Jun-2023Novel recombinant protein to manufacture biologically fit cells by safely lengthening telomeres
Join the club for FREE to access the whole archive and other member benefits.
Biotechnology company to develop anti-ageing therapies via telomeres
Telos Biotech is a Cambrian Bio's third PipeCo launched to overcome cell aging and replicative lifespan limits caused by critically short telomeres. It is on a mission to rapidly and safely lengthen the shortest telomeres, helping to ensure that engineered cells are therapeutically robust.
Telovance is a protein complex that is delivered during the ex-vivo expansion stage of cell manufacturing, to enhance the next generation of cell therapies and enable more sophisticated, multi-step cell engineering technologies.
Visit website: https://www.telosbio.com/
Details last updated 02-Jul-2023
Novel recombinant protein to manufacture biologically fit cells by safely lengthening telomeres